NO20010860L - Nye forbindelser - Google Patents

Nye forbindelser

Info

Publication number
NO20010860L
NO20010860L NO20010860A NO20010860A NO20010860L NO 20010860 L NO20010860 L NO 20010860L NO 20010860 A NO20010860 A NO 20010860A NO 20010860 A NO20010860 A NO 20010860A NO 20010860 L NO20010860 L NO 20010860L
Authority
NO
Norway
Prior art keywords
new connections
prevention
formula
treatment
acceptable salts
Prior art date
Application number
NO20010860A
Other languages
English (en)
Norwegian (no)
Other versions
NO20010860D0 (no
Inventor
Amin Kosrat
Mikael Dahlstroem
Peter Nordberg
Ingemar Starke
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of NO20010860D0 publication Critical patent/NO20010860D0/no
Publication of NO20010860L publication Critical patent/NO20010860L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
NO20010860A 1998-08-21 2001-02-20 Nye forbindelser NO20010860L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9802794A SE9802794D0 (sv) 1998-08-21 1998-08-21 New compounds
PCT/SE1999/001402 WO2000011000A2 (en) 1998-08-21 1999-08-18 New compounds

Publications (2)

Publication Number Publication Date
NO20010860D0 NO20010860D0 (no) 2001-02-20
NO20010860L true NO20010860L (no) 2001-04-23

Family

ID=20412307

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20010860A NO20010860L (no) 1998-08-21 2001-02-20 Nye forbindelser

Country Status (20)

Country Link
US (3) US6579884B1 (es)
EP (2) EP1105391B1 (es)
JP (1) JP2002523415A (es)
KR (1) KR20010072798A (es)
CN (1) CN1329613A (es)
AR (1) AR020226A1 (es)
AT (1) ATE280768T1 (es)
AU (1) AU5767999A (es)
BR (1) BR9913103A (es)
CA (1) CA2339286A1 (es)
DE (1) DE69921483T2 (es)
DK (1) DK1105391T3 (es)
ES (1) ES2229763T3 (es)
IL (1) IL141166A0 (es)
NO (1) NO20010860L (es)
PT (1) PT1105391E (es)
SE (1) SE9802794D0 (es)
SI (1) SI1105391T1 (es)
WO (1) WO2000011000A2 (es)
ZA (1) ZA200100913B (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9802794D0 (sv) * 1998-08-21 1998-08-21 Astra Ab New compounds
SE0003186D0 (sv) * 2000-09-07 2000-09-07 Astrazeneca Ab New process
UA80393C2 (uk) 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
SE0102808D0 (sv) * 2001-08-22 2001-08-22 Astrazeneca Ab New compounds
MY140561A (en) 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
MY136840A (en) * 2002-09-19 2008-11-28 Schering Corp Pyrazolopyridines as cyclin dependent kinase inhibitors
ATE378336T1 (de) * 2002-09-19 2007-11-15 Schering Corp Imidazopyridine als hemmstoffe cyclin abhängiger kinasen
ME00524B (me) 2003-03-10 2011-10-10 Astrazeneca Ab Novi postupak za dobijanje roflumilasta
SE0301904D0 (sv) 2003-06-26 2003-06-26 Astrazeneca Ab Novel imidazopyridine compound II with therapeutic effect
US8536492B2 (en) * 2003-10-27 2013-09-17 Applied Materials, Inc. Processing multilayer semiconductors with multiple heat sources
CN101361738A (zh) 2003-11-03 2009-02-11 阿斯利康(瑞典)有限公司 治疗隐匿性胃食管反流的咪唑并[1,2-a]吡啶衍生物
WO2005070927A2 (en) * 2004-01-26 2005-08-04 Altana Pharma Ag 1,2,4-triazolo[1,5-a] pyridines as gastric acid secretion inhibitors
KR101764575B1 (ko) * 2004-07-28 2017-08-03 다케다 야쿠힌 고교 가부시키가이샤 피롤로〔2,3-ｃ〕피리딘 화합물, 그 제조 방법 및 용도
JP5383183B2 (ja) * 2005-03-16 2014-01-08 タケダ ゲゼルシャフト ミット ベシュレンクテル ハフツング ロフルミラストを含有する矯味された剤形
WO2008065199A1 (en) * 2006-12-01 2008-06-05 Galapagos N.V. Imidazolopyridine compounds useful for the treatment of degenerative and inflammatory diseases
AU2008304231A1 (en) * 2007-09-27 2009-04-02 Albany Molecular Research, Inc. Isoindoline compounds for the treatment of spinal muscular atrophy and other uses
CN102470126A (zh) 2009-07-09 2012-05-23 拉夸里亚创药株式会社 用于治疗与异常肠胃运动有关的疾病的酸泵拮抗剂
CN111606846A (zh) * 2020-05-12 2020-09-01 广州理文科技有限公司 一种n`-三氟甲磺酰基n杂芳香胺类化合物及其制备方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA81219B (en) 1980-01-23 1982-01-27 Schering Corp Imidazo (1,2-a) pyridines ,process for their preparation and pharmaceutical compositions containing them
EP0068378B1 (en) * 1981-06-26 1986-03-05 Schering Corporation Novel imidazo(1,2-a)pyridines and pyrazines, processes for their preparation and pharmaceutical compositions containing them
US4725601A (en) 1985-06-04 1988-02-16 Fujisawa Pharmaceutical Co., Ltd. Certain imidazo[1,2-a]pyridines useful in the treatment of ulcers
US5574042A (en) * 1992-11-02 1996-11-12 Fujisawa Pharmaceutical Co., Ltd Imidazo [1,2-a] pyridines and their pharmaceutical use
IL108520A (en) 1993-02-15 1997-09-30 Byk Gulden Lomberg Chem Fab 2, 3, 8-TRISUBSTITUTED IMIDAZO £1, 2-a| PYRIDINE DERIVATIVES, PROCESSES FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
DK0695303T3 (da) 1993-04-22 2002-03-11 Byk Gulden Lomberg Chem Fab Hidtil ukendte pyridiniumsalte og deres anvendelse til bekæmpelse af Helicobacter-bakterier
UA48122C2 (uk) * 1993-10-11 2002-08-15 Бік Гульден Ломберг Хеміше Фабрік Гмбх АЛКОКСІАЛКІЛКАРБАМАТИ ІМІДАЗО[1,2-а]ПІРИДИНІВ, СПОСІБ ЇХ ОДЕРЖАННЯ ТА ЛІКАРСЬКИЙ ЗАСІБ НА ЇХ ОСНОВІ
HU220874B1 (en) * 1994-07-28 2002-06-29 Byk Gulden Lomberg Chem Fab Imidazopyridine-azolidinones, process for producing them, the use thereof and pharmaceutical compositions containing them
EP0773945A1 (de) * 1994-07-28 1997-05-21 Byk Gulden Lomberg Chemische Fabrik GmbH Acylimidazopyridine
EP0772614A1 (de) * 1994-07-28 1997-05-14 Byk Gulden Lomberg Chemische Fabrik GmbH Halogenimidazopyridine
NZ290818A (en) * 1994-07-28 1998-10-28 Byk Gulden Lomberg Chem Fab Benzyl-imidazopyridines
DE19602853A1 (de) * 1996-01-26 1997-07-31 Byk Gulden Lomberg Chem Fab Neue Halogenimidazopyridine
JP2000513710A (ja) 1996-01-26 2000-10-17 ビイク グルデン ロンベルク ヒエーミツシエ フアブリーク ゲゼルシヤフト ミツト ベシユレンクテル ハフツング ３―メチルイミダゾピリジン
SE9700661D0 (sv) * 1997-02-25 1997-02-25 Astra Ab New compounds
SE9801526D0 (sv) * 1998-04-29 1998-04-29 Astra Ab New compounds
SE9802793D0 (sv) * 1998-08-21 1998-08-21 Astra Ab New compounds
SE9802794D0 (sv) * 1998-08-21 1998-08-21 Astra Ab New compounds

Also Published As

Publication number Publication date
WO2000011000A3 (en) 2000-06-15
SE9802794D0 (sv) 1998-08-21
PT1105391E (pt) 2005-01-31
ATE280768T1 (de) 2004-11-15
DE69921483T2 (de) 2006-02-02
DK1105391T3 (da) 2005-01-24
CN1329613A (zh) 2002-01-02
CA2339286A1 (en) 2000-03-02
NO20010860D0 (no) 2001-02-20
KR20010072798A (ko) 2001-07-31
EP1105391B1 (en) 2004-10-27
AU5767999A (en) 2000-03-14
WO2000011000A2 (en) 2000-03-02
US6579884B1 (en) 2003-06-17
US20030220364A1 (en) 2003-11-27
BR9913103A (pt) 2001-05-08
US20050154007A1 (en) 2005-07-14
JP2002523415A (ja) 2002-07-30
DE69921483D1 (de) 2004-12-02
IL141166A0 (en) 2002-02-10
EP1411056A2 (en) 2004-04-21
ZA200100913B (en) 2002-05-02
AR020226A1 (es) 2002-05-02
SI1105391T1 (en) 2005-02-28
EP1411056A3 (en) 2004-04-28
EP1105391A2 (en) 2001-06-13
US6790960B2 (en) 2004-09-14
ES2229763T3 (es) 2005-04-16

Similar Documents

Publication Publication Date Title
NO20010860L (no) Nye forbindelser
NO20010861L (no) Nye forbindelser
SE9801526D0 (sv) New compounds
SE9704404D0 (sv) New compounds
TR200100805T2 (tr) Tetrahidropiridoeterler
SE9700661D0 (sv) New compounds
SE9401197D0 (sv) Active compounds
CA2256687A1 (en) Benzimidazole derivatives for treating gastrointestinal inflammatory diseases
ATE311389T1 (de) Wirkstoffvorläufer von imidazopyridin-derivaten
MXPA04001402A (es) Compuestos de imidazopiridina novedosos con efecto terapeutico.
WO2002074735A3 (de) Biurethanderivate
NO954928L (no) Nye aktive forbindelser
SE0102640D0 (sv) Novel compounds
SE0301905D0 (sv) Novel imidazopyridine compound I with therapeutic effect
NZ329716A (en) Sulfonamide substituted derivatives and medicaments thereof
MX9704136A (es) Compuestos para la inhibicion de la secrecion de acido gastrico.
SE0301903D0 (sv) Novel imidazopyridine compound III with therapeutic effect
NO20072340L (no) Difluorsubstituerte Imidazopyridiner
SE0202279D0 (sv) Novel comppounds
AR044854A1 (es) Compuesto de imidazopiridina
NO20012101L (no) Fremgangsmåte for fremstilling av <alfa>-arylalkansyrer

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application